Home › Funds › Atle Fund Management AB › CMPX

Atle Fund Management AB position in CMPX

COMPASS THERAPEUTICS INC · Health Care

Atle Fund Management AB reported holding 1,048,593 shares of CMPX (COMPASS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.3M, representing 0.62% of its reported portfolio and ranking #38 among its reported holdings. Atle Fund Management AB has disclosed CMPX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.05M sh
Reported value held$2.30M
Portfolio Weight0.62%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's CMPX position evolved

Atle Fund Management AB first disclosed a stake in CMPX in Q4 2025 at 584,332 shares (US$3.1M). Across 3 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,048,593 shares valued at US$2.3M — an increase of 1,006,762 shares quarter over quarter.. Notable position changes include a 93% trim in Q1 2026 (shares fell 59% over the following quarter), a 2407% increase in Q2 2026 (shares fell 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 584.33K $3.14M New
Q1 2026 41.83K $3.05M Reduce
Q2 2026 1.05M $2.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CMPX and 13F data

CMPX (COMPASS THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in CMPX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$39.4M), ORBIMED ADVISORS LLC (US$33.3M), MONTANOVA CAPITAL, LLC (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CMPX

All CMPX fund holders →

FAQ

How long has Atle Fund Management AB held CMPX?

Atle Fund Management AB has disclosed CMPX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Atle Fund Management AB's current position in CMPX?

As of Q2 2026, Atle Fund Management AB holds 1.05M shares of CMPX (COMPASS THERAPEUTICS INC), valued at $2.30M, representing 0.62% of its reported portfolio and ranking #38.

Has Atle Fund Management AB been buying or selling CMPX?

In the latest 13F filing (Q2 2026), Atle Fund Management AB increased its position in CMPX.

Which other funds hold CMPX?

Other major institutional holders of CMPX include TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.